Ads
related to: what is myeloid leukemia- Side Effects On Treatment
Learn About Possible Side Effects
And Considerations With Treatment.
- CML Treatment
Visit The Patient Website To
Learn More About This Treatment.
- Understanding CML
Patients With Ph+ CML-CP
Learn About A Treatment Option.
- Doctor Discussion Guide
Find The Patient Guide & Other
Helpful Resources Here.
- $0 Co-Pay Information
You May Be Eligible To Save On
Your Next Rx. Learn More Here.
- Side Effects & Safety
Learn About Possible Side Effects
You May Experience During Treatment
- Side Effects On Treatment
Search results
Results From The WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Myeloid leukemia is a type of leukemia affecting myeloid tissue. Types include: Acute myeloid leukemia : A cancer of the myeloid line of blood cells , characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production .
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood.
For example, people with Down syndrome have a significantly increased risk of developing forms of acute leukemia (especially acute myeloid leukemia), and Fanconi anemia is a risk factor for developing acute myeloid leukemia. [46] Mutation in SPRED1 gene has been associated with a predisposition to childhood leukemia. [54]
Acute myeloid leukemia is a very heterogeneous disease, composed of a variety of translocations and mutations. However, one tenth of all acute myeloid leukemia cases diagnosed have the AML1-ETO fusion oncoprotein due to the t(8;21) translocation. AML1 or RUNX1 is a DNA-binding transcription factor located at the 21q22.
Clonal expansion of the abnormal cells results in the production of cells that have lost the ability to differentiate. If the overall percentage of bone-marrow myeloblasts rises over a particular cutoff (20% for WHO and 30% for FAB), then transformation to acute myelogenous leukemia (AML) is said to have occurred.
Ads
related to: what is myeloid leukemia